|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 18.50 USD | +0.71% |
|
+2.74% | +4.14% |
| 16/06 | Zai Lab Receives EU Orphan Drug Designation for Lung Cancer Drug | MT |
| 10/06 | Asian Equities Traded in the US as American Depositary Receipts Lower in Wednesday Trading | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Sector Biopharmaceuticals
| Capi. | Sales Growth | Profitability | Finances | EV / Sales | P/E | |
|---|---|---|---|---|---|---|
 | 206.4Cr | - | ||||
| 6.34TCr | |||||
| 5.51TCr | |||||
| 4.16TCr | |||||
| 3.8TCr | - | ||||
| 2.95TCr |
- Stock Market
- Stocks
- ZLAB Stock
- Charts Zai Lab Limited
- Sector Chart
Select your edition
All financial news and data tailored to specific country editions
